TY - JOUR
T1 - Changes in pain intensity after discontinuation of long-term opioid therapy for chronic noncancer pain
AU - McPherson, Sterling
AU - Smith, Crystal Lederhos
AU - Dobscha, Steven K.
AU - Morasco, Benjamin J.
AU - Demidenko, Michael I.
AU - Meathd, Thomas H.A.
AU - Lovejoy, Travis I.
N1 - Funding Information:
This work was supported by a center pilot grant to S. McPherson and T.I. Lovejoy from the U.S. Department of Veterans Affairs Health Services Research & Development Center to Improve Veteran Involvement in Care at the VA Portland Health Care System, and Locally Initiated Project Award # QLP 59-048 (PI: T.I.L.) from the U.S. Department of Veterans Affairs Substance Use Disorder Quality Enhancement Research Initiative. T.I. Lovejoy received additional support from Career Development Award IK2HX001516 from the U.S. Department of Veterans Affairs Health Services Research and Development during preparation of this manuscript.
Funding Information:
T.I. Lovejoy reports grants from the U.S. Department of Veterans Affairs Health Services Research & Development during the conduct of the study. S. McPherson has received research funding from Ringful Health, Consistent Care, and the Orthopedic Specialty Institute. The remaining authors have no conflict of interest to declare.
Publisher Copyright:
© 2018 by the International Association for the Study of Pain.
PY - 2018
Y1 - 2018
N2 - Little is known about changes in pain intensity that may occur after discontinuation of long-term opioid therapy (LTOT). The objective of this study was to characterize pain intensity after opioid discontinuation over 12 months. This retrospective U.S. Department of Veterans Affairs (VA) administrative data study identified N = 551 patients nationally who discontinued LTOT. Data over 24 months (12 months before and after discontinuation) were abstracted from VA administrative records. Random-effects regression analyses examined changes in 0 to 10 pain numeric rating scale scores over time, whereas growth mixture models delineated pain trajectory subgroups. Mean estimated pain at the time of opioid discontinuation was 4.9. Changes in pain after discontinuation were characterized by slight but statistically nonsignificant declines in pain intensity over 12 months after discontinuation (B = 20.20, P = 0.14). Follow-up growth mixture models identified 4 pain trajectory classes characterized by the following postdiscontinuation pain levels: no pain (average pain at discontinuatioN = 0.37), mild clinically significant pain (average paiN = 3.90), moderate clinically significant pain (average paiN = 6.33), and severe clinically significant pain (average paiN = 8.23). Similar to the overall sample, pain trajectories in each of the 4 classes were characterized by slight reductions in pain over time, with patients in the mild and moderate pain trajectory categories experiencing the greatest pain reductions after discontinuation (B = 20.11, P = 0.05 and B = 20.11, P = 0.04, respectively). Pain intensity after discontinuation of LTOT does not, on average, worsen for patients and may slightly improve, particularly for patients with mild-to-moderate pain at the time of discontinuation. Clinicians should consider these findings when discussing risks of opioid therapy and potential benefits of opioid taper with patients.
AB - Little is known about changes in pain intensity that may occur after discontinuation of long-term opioid therapy (LTOT). The objective of this study was to characterize pain intensity after opioid discontinuation over 12 months. This retrospective U.S. Department of Veterans Affairs (VA) administrative data study identified N = 551 patients nationally who discontinued LTOT. Data over 24 months (12 months before and after discontinuation) were abstracted from VA administrative records. Random-effects regression analyses examined changes in 0 to 10 pain numeric rating scale scores over time, whereas growth mixture models delineated pain trajectory subgroups. Mean estimated pain at the time of opioid discontinuation was 4.9. Changes in pain after discontinuation were characterized by slight but statistically nonsignificant declines in pain intensity over 12 months after discontinuation (B = 20.20, P = 0.14). Follow-up growth mixture models identified 4 pain trajectory classes characterized by the following postdiscontinuation pain levels: no pain (average pain at discontinuatioN = 0.37), mild clinically significant pain (average paiN = 3.90), moderate clinically significant pain (average paiN = 6.33), and severe clinically significant pain (average paiN = 8.23). Similar to the overall sample, pain trajectories in each of the 4 classes were characterized by slight reductions in pain over time, with patients in the mild and moderate pain trajectory categories experiencing the greatest pain reductions after discontinuation (B = 20.11, P = 0.05 and B = 20.11, P = 0.04, respectively). Pain intensity after discontinuation of LTOT does not, on average, worsen for patients and may slightly improve, particularly for patients with mild-to-moderate pain at the time of discontinuation. Clinicians should consider these findings when discussing risks of opioid therapy and potential benefits of opioid taper with patients.
KW - Chronic noncancer pain
KW - Long-term opioid therapy
KW - Pain intensity
KW - Prescription opioid discontinuation
KW - Veterans
UR - http://www.scopus.com/inward/record.url?scp=85057711135&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85057711135&partnerID=8YFLogxK
U2 - 10.1097/j.pain.0000000000001315
DO - 10.1097/j.pain.0000000000001315
M3 - Article
C2 - 29905648
AN - SCOPUS:85057711135
SN - 0304-3959
VL - 159
SP - 2097
EP - 2104
JO - Pain
JF - Pain
IS - 10
ER -